In responders to IMiDs, IMiDs are able to stimulate immune effector cells to enhance IFN-γ production in an ambient tumor microenvironment, which can stimulate the IFN-γ-STAT1 pathway in MM cells. This evidence concerns the gene IFNG and neoplasm.